Difference between revisions of "Part:BBa K5175036"
Line 51: | Line 51: | ||
width="700" | width="700" | ||
title=""> | title=""> | ||
− | <figcaption>Fig. | + | <figcaption>Fig.2 The bands of T7-tphB-tpaK(~2000+ bp)from PCR |
<br><br>The bands of T7-tphB-tpaK(~2000+ bp)from PCR are identical to the theoretical lengths of 2576 bp estimated by the designed primer locations (promoter to terminator), which could demonstrate that these plasmids had successfully been obtained. | <br><br>The bands of T7-tphB-tpaK(~2000+ bp)from PCR are identical to the theoretical lengths of 2576 bp estimated by the designed primer locations (promoter to terminator), which could demonstrate that these plasmids had successfully been obtained. | ||
Latest revision as of 10:50, 2 October 2024
T7 promoter - tphB-tpaK-T7 terminator
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 1906
Illegal PstI site found at 2195 - 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 2462
Illegal PstI site found at 1906
Illegal PstI site found at 2195 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 242
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 1906
Illegal PstI site found at 2195 - 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 1906
Illegal PstI site found at 2195
Illegal NgoMIV site found at 289
Illegal NgoMIV site found at 964 - 1000COMPATIBLE WITH RFC[1000]
Description
It is a composite component consisting of the T7 promoter, T7 terminator, target genes tphB, tpaK. It is responsible for oxidising the diol moiety (two hydroxyl groups) of DCD to a keto group to result in the production of PCA and transporting TPA.
Usage and Biology
TPA 1,2-dioxygenase (TPADO) is a two-component oxygenase consisting of three parts, TphA1, TphA2, and TphA3, which together enable TPADO to effectively catalyze the oxidative reaction of TPA, converting TPA to the intermediate product 1,2-dihydroxy-3,5-cyclohexadiene-1,4-dicarboxylic acid (DCD). TphA2, TphA3 constitute the large and small subunits of the TPADO oxidase component responsible for binding to the TPA substrate and catalyzing the oxygenation reaction in the active site.TphA2 contains the active site in direct contact with the substrate, TPA, and contains the Cys-X1-His X17-Cys-X2-His pattern, binds to Rieske-type [2Fe-2S] iron-sulfur clusters and participates in electron transfer, which is a key part of the catalytic reaction of dioxygenases , TphA3 participates in the construction of the substrate channel or the appropriate positioning of the active site, and assists TphA2 in completing the oxidation reaction; TphA1 does not directly participate in the oxygenation reaction, but it contains a [2Fe -2S] iron-sulfur cluster and a flavin adenine dinucleotide (FAD) binding site that transfers electrons from an electron donor (e.g., NADPH) to the oxidized component of TPADO.
TphB
TphB is a dehydrogenase that oxidizes the diol moiety (two hydroxyl groups) of DCD to a keto group, resulting in the production of PCA.
TpaK
tpaK is a TPA transporter protein does not require other proteins for TPA transportation
html>
Molecular cloning
Initially, we transformed the company-synthesized plasmids containing designed sequences into E. coli DH5α for amplification, allowing us to obtain a sufficient quantity of plasmid DNA for subsequent experiments. Following this, colony PCR was performed to confirm successful transformation, and the required plasmids were subsequently extracted for further experimentation.Subsequently, we employed PCR to obtain the target fragments, which were then integrated into the requisite plasmids for our study.We constructed three plasmids for P. putida KT2440: pTerephthalate-A, pTerephthalate-B, and pRhamnolipid. We verified the size of each plasmid as well as all the fragments involved in constructing the plasmids . The plasmids were successfully introduced into *Pseudomonas putida* through electroporation. Given that our wild-type Pseudomonas putida exhibits resistance to chloramphenicol, the plasmids incorporated a kanamycin resistance marker. Consequently, we employed dual antibiotic selection plates to effectively screen for successfully transformed engineered strains. html> html>